Omblastys

iodine-131 omburtamab · Y-Mabs Therapeutics A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Omblastys, covering 2023-06-14 to 2023-06-14. Get the full timeline:

Most recent: EMA Refused: Omblastys (iodine (131I) omburtamab) — Y-Mabs Therapeutics A/S